August 17, 2022
Coronavirus Europe Germany news Vaccines and immunisation World news

Approval of new Covid jab raises hopes of persuading Germany’s unvaccinated

First doses of protein-based Nuvaxovid are expected to be used in new year after European Medicines Agency gives go-ahead

The approval of a new protein-based Covid-19 vaccine by the European Medicines Agency (EMA) has led to hopes that it could play an important role in persuading millions of Germans who have refused jabs from existing vaccines to get protection against the disease this winter.

The EMA approved the two-dose Novavax vaccine on Monday afternoon. The German government’s vaccination advisory board is expected to follow suit and allow for its use soon, a move that would be welcomed by health experts who are bracing for a huge and imminent wave of infections caused by the new Omicron variant. The first doses of Novavax are expected to be administered in Germany in the new year.

Continue reading…

Related posts

Magnolia species lost to science for 97 years rediscovered in Haiti

admin7932

‘Magnificent’ jellyfish found off coast of Papua New Guinea sparks interest among researchers

admin7932

Canada exempts Russian gas turbine from sanctions amid Europe energy crisis

admin7932